These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
339 related items for PubMed ID: 32745221
21. Is Treatment with Denosumab Associated with Local Recurrence in Patients with Giant Cell Tumor of Bone Treated with Curettage? A Systematic Review. Tsukamoto S, Tanaka Y, Mavrogenis AF, Kido A, Kawaguchi M, Errani C. Clin Orthop Relat Res; 2020 May; 478(5):1076-1085. PubMed ID: 31794487 [Abstract] [Full Text] [Related]
22. Denosumab in patients with giant-cell tumour of bone: a multicentre, open-label, phase 2 study. Chawla S, Blay JY, Rutkowski P, Le Cesne A, Reichardt P, Gelderblom H, Grimer RJ, Choy E, Skubitz K, Seeger L, Schuetze SM, Henshaw R, Dai T, Jandial D, Palmerini E. Lancet Oncol; 2019 Dec; 20(12):1719-1729. PubMed ID: 31704134 [Abstract] [Full Text] [Related]
26. A randomized phase III trial of denosumab before curettage for giant cell tumor of bone: Japan Clinical Oncology Group Study JCOG1610. Urakawa H, Mizusawa J, Tanaka K, Eba J, Hiraga H, Kawai A, Nishida Y, Hosaka M, Iwamoto Y, Fukuda H, Ozaki T. Jpn J Clin Oncol; 2019 Apr 01; 49(4):379-382. PubMed ID: 30796832 [Abstract] [Full Text] [Related]
29. Malignancy in giant cell tumor of bone: analysis of an open-label phase 2 study of denosumab. Palmerini E, Seeger LL, Gambarotti M, Righi A, Reichardt P, Bukata S, Blay JY, Dai T, Jandial D, Picci P. BMC Cancer; 2021 Jan 22; 21(1):89. PubMed ID: 33482769 [Abstract] [Full Text] [Related]
31. Giant cell tumour of bone in the denosumab era. van der Heijden L, Dijkstra PDS, Blay JY, Gelderblom H. Eur J Cancer; 2017 May 22; 77():75-83. PubMed ID: 28365529 [Abstract] [Full Text] [Related]
32. Denosumab treatment of inoperable or locally advanced giant cell tumor of bone - Multicenter analysis outside clinical trial. Rutkowski P, Gaston L, Borkowska A, Stacchiotti S, Gelderblom H, Baldi GG, Palmerini E, Casali P, Gronchi A, Parry M, Campanacci DA, Scoccianti G, Wagrodzki M, Ferrari S, Dijkstra S, Pieńkowski A, Grimer R. Eur J Surg Oncol; 2018 Sep 22; 44(9):1384-1390. PubMed ID: 29650420 [Abstract] [Full Text] [Related]
33. Surgical challenges, novel techniques, and systemic treatment of giant cell tumour of bone of the distal radius : clinical outcomes and systematic review of the literature. van der Heijden L, Bindt S, Scorianz M, Ng C, Gibbons MCLH, van de Sande MAJ, Campanacci DA. Bone Jt Open; 2022 Jul 22; 3(7):515-528. PubMed ID: 35775196 [Abstract] [Full Text] [Related]
36. Factors of local recurrence of giant cell tumor of long bone after treatment: plain radiographs, pathology and surgical procedures. Chanchairujira K, Jiranantanakorn T, Phimolsarnti R, Asavamongkolkul A, Waikakul S. J Med Assoc Thai; 2011 Oct 22; 94(10):1230-7. PubMed ID: 22145509 [Abstract] [Full Text] [Related]
39. The use of denosumab in the setting of acute pathological fracture through giant cell tumour of bone. Weschenfelder W, Abrahams JM, Johnson LJ. World J Surg Oncol; 2021 Feb 02; 19(1):37. PubMed ID: 33530997 [Abstract] [Full Text] [Related]
40. Giant cell tumour of bone. Aoude A, Nikomarov D, Perera JR, Ibe IK, Griffin AM, Tsoi KM, Ferguson PC, Wunder JS. Bone Joint J; 2023 May 01; 105-B(5):559-567. PubMed ID: 37121582 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]